Sana Biotechnology, Inc. (SANA)
SANA Stock Price Chart
Explore Sana Biotechnology, Inc. interactive price chart. Choose custom timeframes to analyze SANA price movements and trends.
SANA Company Profile
Discover essential business fundamentals and corporate details for Sana Biotechnology, Inc. (SANA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Feb 2021
Employees
194.00
Website
https://www.sana.comCEO
Steven D. Harr
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.
SANA Financial Timeline
Browse a chronological timeline of Sana Biotechnology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is -$0.18.
Earnings released on 11 Aug 2025
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%.
Earnings released on 8 May 2025
EPS came in at -$0.20 surpassing the estimated -$0.22 by +9.09%.
Earnings released on 17 Mar 2025
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%.
Earnings released on 8 Nov 2024
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%.
Earnings released on 8 Aug 2024
EPS came in at -$0.32 falling short of the estimated -$0.27 by -18.52%.
Earnings released on 8 May 2024
EPS came in at -$0.32 falling short of the estimated -$0.30 by -6.67%.
Earnings released on 29 Feb 2024
EPS came in at -$0.35 surpassing the estimated -$0.37 by +5.41%.
Earnings released on 8 Nov 2023
EPS came in at -$0.41 surpassing the estimated -$0.42 by +2.38%.
Earnings released on 3 Aug 2023
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 8 May 2023
EPS came in at -$0.43 falling short of the estimated -$0.38 by -13.16%.
Earnings released on 16 Mar 2023
EPS came in at -$0.40 surpassing the estimated -$0.41 by +2.44%.
Earnings released on 2 Nov 2022
EPS came in at -$0.48 falling short of the estimated -$0.39 by -23.08%.
Earnings released on 4 Aug 2022
EPS came in at -$0.47 falling short of the estimated -$0.46 by -2.17%.
Earnings released on 10 May 2022
EPS came in at -$0.47 falling short of the estimated -$0.38 by -23.68%.
Earnings released on 16 Mar 2022
EPS came in at -$0.65 falling short of the estimated $0.36 by -280.56%.
Earnings released on 8 Nov 2021
EPS came in at -$0.37 falling short of the estimated -$0.29 by -27.59%.
Earnings released on 4 Aug 2021
EPS came in at -$0.32 surpassing the estimated -$0.37 by +13.51%.
Earnings released on 5 May 2021
EPS came in at -$0.45 falling short of the estimated -$0.35 by -28.57%.
Earnings released on 24 Mar 2021
EPS came in at -$2.98 falling short of the estimated -$0.41 by -626.83%, while revenue for the quarter reached $161.53M .
Earnings released on 5 Feb 2021
EPS came in at -$0.39 .
SANA Stock Performance
Access detailed SANA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.